Credit Suisse’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $273K | Sell |
|
|||||
|
2023
Q2 | $836K | Buy |
|
|||||
|
2023
Q1 | $840K | Sell |
|
|||||
|
2022
Q4 | $10.2M | Sell |
|
|||||
|
2022
Q3 | $22.8M | Buy |
|
|||||
|
2022
Q2 | $24.9M | Sell |
|
|||||
|
2022
Q1 | $39.1M | Buy |
|
|||||
|
2021
Q4 | $58.4M | Sell |
|
|||||
|
2021
Q3 | $60.1M | Buy |
|
|||||
|
2021
Q2 | $87.5M | Buy |
|
|||||
|
2021
Q1 | $83M | Buy |
|
|||||
|
2020
Q4 | $69.1M | Buy |
|
|||||
|
2020
Q3 | $29.8M | Sell |
|
|||||
|
2020
Q2 | $27.5M | Buy |
|
|||||
|
2020
Q1 | $15.4M | Sell |
|
|||||
|
2019
Q4 | $16.6M | Buy |
|
|||||
|
2019
Q3 | $13.1M | Buy |
|
|||||
|
2019
Q2 | $14.8M | Buy |
|
|||||
|
2019
Q1 | $1.15M | Buy |
|
|||||
|
2018
Q4 | $705K | Buy |
|
|||||
|
2018
Q3 | $407K | Sell |
|
|||||
|
2018
Q2 | $376K | Buy |
|
|||||
|
2018
Q1 | $174K | Buy |
|
|||||
|
2017
Q4 | $69K | Sell |
|
|||||
|
2017
Q3 | $112K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $56K | Buy |
|